[Production conditions and properties of the new antineoplastic antibiotic No. 294].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000096:biosynthesis* / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D002855:Chromatography, Thin Layer; D003470:Culture Media; D003864:Depression, Chemical; D004755:Enterobacteriaceae / Q000187:drug effects; D056890:Eukaryota / Q000187:drug effects; D007259:Infrared Rays; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D051379:Mice; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors; D009696:Nucleic Acids / Q000032:analysis; D012510:Sarcoma 180 / Q000188:drug therapy*; D012511:Sarcoma 37 / Q000188:drug therapy*; D013057:Spectrum Analysis; D013268:Stimulation, Chemical; D013302:Streptomyces / Q000032:analysis / Q000166:cytology / Q000254:growth & development / Q000378:metabolism*
D000903:Antibiotics, Antineoplastic; D003470:Culture Media; D009363:Neoplasm Proteins; D009696:Nucleic Acids
Usloviia obrazovaniia i svoĭstva novogo proti voopukholevogo antibiotika No. 294.